The series Animals & Us explores the strong connection between the health of animals and people. In GALVmed’s film, we explore how innovation, collaboration, and vaccination of livestock help protect animals, strengthen communities, and advance One Health.
This video was produced for GALVmed by BBC StoryWorks Commercial Productions.
We’re excited to share GALVmed’s 2025 Year in Review, an overview of our accomplishments and the progress made throughout the year in advancing our mission.
The review reflects a year of meaningful impact and our continued commitment to strengthening livelihoods through improved livestock health.
Read it here.
Transformational improvement in the well-being and economic progression of small-scale livestock producers.
We will contribute to the transformation of small-scale livestock producers’ lives by:
Product development
GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.
Commercial development
Our work with our partners supports the small-scale livestock producers of the world.
Enabling environment
An enabling environment that allows for the successful translation of research products to sustainable animal health solutions for small scale livestock producers is essential to achieving GALVmed’s mission.
Livestock face a myriad of deadly diseases. Many feel there is need to accelerate the development and distribution of vaccines for chickens, cows, sheep and goats. But small homestead farmers in rural areas can struggle to access these life-saving medicines and vaccines. That’s why GALVmed aims to bring vaccines straight to their door.
The series Animals & Us explores the strong connection between the health of animals and people.
In GALVmed’s film, we explore how innovation, collaboration, and vaccination of livestock help protect animals, strengthen communities, and advance One Health.
Government leaders, veterinary professionals, development partners, academics, and private sector stakeholders came together to deliberate on solutions to the challenges facing the livestock health sector.
Livestock face a myriad of deadly diseases. Many feel there is need to accelerate the development and distribution of vaccines for chickens, cows, sheep and goats. But small homestead farmers in rural areas can struggle to access these life-saving medicines and vaccines. That’s why GALVmed aims to bring vaccines straight to their door.
The series Animals & Us explores the strong connection between the health of animals and people.
In GALVmed’s film, we explore how innovation, collaboration, and vaccination of livestock help protect animals, strengthen communities, and advance One Health.
A new joint policy brief by FAO, WOAH and AU-IBAR advocates for a multi-stakeholder and multi-sectoral collaboration to deliver a new generation of trypanocides for the African livestock sector.
The candidate vaccine is a novel target identified on the surface of haemorrhagic septicaemia-associated strains of Pasteurella multocida. It has demonstrated robust protection in cattle against lethal challenge with the two serogroups of Pasteurella responsible for HS.
Applying a gender lens to livestock programmes is not an optional add-on, but a strategic necessity. VITAL 2 is a gender-intentional investment, designed to ensure that gender-related barriers and norms are identified and addressed so that women are not excluded from the benefits of ruminant vaccination as markets and delivery systems expand.